Mitsubishi UFJ Trust & Banking’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$538M Buy
448,840
+4,050
+0.9% +$4.14M 1.18% 11
2026
Q1
$409M Buy
444,790
+5,558
+1% +$5.63M 1.01% 11
2025
Q4
$472M Buy
439,232
+11,619
+3% +$11.1M 1.12% 10
2025
Q3
$326M Sell
427,613
-11,939
-3% -$8.88M 0.72% 16
2025
Q2
$343M Sell
439,552
-7,558
-2% -$5.87M 0.79% 14
2025
Q1
$369M Sell
447,110
-7,137
-2% -$5.94M 0.96% 11
2024
Q4
$351M Sell
454,247
-23,916
-5% -$19.8M 0.82% 13
2024
Q3
$424M Sell
478,163
-17,588
-4% -$15.8M 0.97% 9
2024
Q2
$449M Sell
495,751
-21,018
-4% -$16.8M 1.07% 9
2024
Q1
$401M Sell
516,769
-28,352
-5% -$20.2M 0.92% 9
2023
Q4
$318M Sell
545,121
-52,512
-9% -$30.7M 0.75% 18
2023
Q3
$321M Sell
597,633
-9,334
-2% -$4.81M 0.8% 15
2023
Q2
$285M Sell
606,967
-7,464
-1% -$3.13M 0.66% 22
2023
Q1
$211M Buy
614,431
+25,179
+4% +$8.49M 0.51% 39
2022
Q4
$216M Buy
589,252
+35,245
+6% +$12.5M 0.56% 35
2022
Q3
$179M Sell
554,007
-28,852
-5% -$9.14M 0.5% 39
2022
Q2
$189M Buy
582,859
+73,155
+14% +$22M 0.48% 42
2022
Q1
$146M Sell
509,704
-23,368
-4% -$6.01M 0.33% 73
2021
Q4
$147M Sell
533,072
-99,930
-16% -$25.3M 0.3% 82
2021
Q3
$146M Sell
633,002
-9,647
-2% -$2.38M 0.32% 75
2021
Q2
$147M Sell
642,649
-109,278
-15% -$22M 0.31% 78
2021
Q1
$139M Sell
751,927
-160,099
-18% -$31.3M 0.31% 77
2020
Q4
$154M Sell
912,026
-39,300
-4% -$5.87M 0.31% 69
2020
Q3
$141M Sell
951,326
-13,634
-1% -$2.11M 0.32% 71
2020
Q2
$158M Sell
964,960
-119,193
-11% -$18.3M 0.38% 57
2020
Q1
$150M Buy
1,084,153
+33,634
+3% +$4.62M 0.44% 47
2019
Q4
$138M Buy
1,050,519
+29,494
+3% +$3.42M 0.33% 70
2019
Q3
$115M Buy
1,021,025
+35,716
+4% +$3.98M 0.29% 79
2019
Q2
$110M Buy
985,309
+65,724
+7% +$7.74M 0.37% 51
2019
Q1
$119M Sell
919,585
-81,429
-8% -$9.9M 0.44% 44
2018
Q4
$116M Sell
1,001,014
-62,360
-6% -$6.97M 0.48% 38
2018
Q3
$114M Sell
1,063,374
-1,267,544
-54% -$127M 0.41% 48
2018
Q2
$199M Buy
2,330,918
+711
+0% +$58.4K 0.34% 64
2018
Q1
$180M Buy
2,330,207
+4,209
+0.2% +$339K 0.32% 69
2017
Q4
$196M Buy
2,325,998
+30,131
+1% +$2.56M 0.34% 62
2017
Q3
$196M Buy
2,295,867
+62,028
+3% +$5.09M 0.36% 59
2017
Q2
$184M Sell
2,233,839
-73,380
-3% -$5.99M 0.36% 59
2017
Q1
$194M Buy
2,307,219
+3,141
+0.1% +$252K 0.39% 48
2016
Q4
$169M Sell
2,304,078
-81,603
-3% -$6.08M 0.36% 60
2016
Q3
$191M Buy
2,385,681
+53,865
+2% +$4.31M 0.4% 50
2016
Q2
$184M Buy
2,331,816
+240,987
+12% +$18.1M 0.4% 48
2016
Q1
$151M Sell
2,090,829
-8,763
-0.4% -$663K 0.34% 64
2015
Q4
$177M Sell
2,099,592
-10,804
-0.5% -$897K 0.4% 52
2015
Q3
$177M Buy
2,110,396
+25,005
+1% +$2.11M 0.43% 49
2015
Q2
$174M Buy
2,085,391
+7,711
+0.4% +$588K 0.4% 54
2015
Q1
$151M Buy
2,077,680
+25,246
+1% +$1.8M 0.35% 62
2014
Q4
$142M Sell
2,052,434
-23,540
-1% -$1.59M 0.34% 68
2014
Q3
$135M Sell
2,075,974
-153,615
-7% -$9.73M 0.33% 69
2014
Q2
$139M Sell
2,229,589
-54,281
-2% -$3.24M 0.32% 71
2014
Q1
$134M Buy
2,283,870
+9,268
+0.4% +$517K 0.33% 66
2013
Q4
$116M Sell
2,274,602
-34,428
-1% -$1.72M 0.29% 80
2013
Q3
$116M Buy
2,309,030
+26,492
+1% +$1.39M 0.31% 69
2013
Q2
$112M Buy
+2,282,538
New +$124M 0.32% 64

Other funds holding LLY

Mitsubishi UFJ Trust & Banking's LLY Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking increased its Eli Lilly (LLY) stake by 0.91% in Q2 2026, buying an estimated $4.14M and bringing the position to 448,840 shares worth $538M. The position accounts for 1.18% of the portfolio, ranked #11.

Mitsubishi UFJ Trust & Banking first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 448,840 shares of Eli Lilly worth $538M as of Q2 2026.
  • Mitsubishi UFJ Trust & Banking bought 4,050 Eli Lilly shares in Q2 2026, an estimated $4.14M.
  • Eli Lilly made up 1.18% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #11 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.